Engagement and Acceptability of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Secondary Findings From a Multicenter Randomized Controlled Trial
JMIR Formative Research · 2024
DOI: 10.2196/57109 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Formative Research, 2024. Verfasst von Evelyne van Aubel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Contextual Psychiatry, Psychiatry Research Group, Department of Neurosciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Acceptance and Commitment Therapy, Psychotic Disorders, Patient Acceptance of Health Care. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: EPA.
Abstract (Originalsprache)
Background
Acceptance and commitment therapy (ACT) is promising in the treatment of early psychosis. Augmenting face-to-face ACT with mobile health ecological momentary interventions may increase its treatment effects and empower clients to take treatment into their own hands.
Objective
This study aimed to investigate and predict treatment engagement with and acceptability of acceptance and commitment therapy in daily life (ACT-DL), a novel ecological momentary intervention for people with an ultrahigh risk state and a first episode of psychosis.
Methods
In the multicenter randomized controlled trial, 148 individuals with ultrahigh risk or first-episode psychosis aged 15-65 years were randomized to treatment as usual only (control) or to ACT-DL combined with treatment as usual (experimental), consisting of 8 face-to-face sessions augmented with an ACT-based smartphone app, delivering ACT skills and techniques in daily life. For individuals in the intervention arm, we collected data on treatment engagement with and acceptability of ACT-DL during and after the intervention. Predictors of treatment engagement and acceptability included baseline demographic, clinical, and functional outcomes.
Results
Participants who received ACT-DL in addition to treatment as usual (n=71) completed a mean of 6 (SD 3) sessions, with 59% (n=42) of participants completing all sessions. App engagement data (n=58) shows that, on a weekly basis, participants used the app 13 times and were compliant with 6 of 24 (25%) notifications. Distribution plots of debriefing scores (n=46) show that 85%-96% of participants reported usefulness on all acceptability items to at least some extent (scores ≥2; 1=no usefulness) and that 91% (n=42) of participants reported perceived burden by number and length of notifications (scores ≥2; 1=no burden). Multiple linear regression models were fitted to predict treatment engagement and acceptability. Ethnic minority backgrounds predicted lower notification response compliance (B=–4.37; P=.01), yet higher app usefulness (B=1.25; P=.049). Negative (B=–0.26; P=.01) and affective (B=0.14; P=.04) symptom severity predicted lower and higher ACT training usefulness, respectively. Being female (B=–1.03; P=.005) predicted lower usefulness of the ACT metaphor images on the app.
Conclusions
Our results corroborate good treatment engagement with and acceptability of ACT-DL in early psychosis. We provide recommendations for future intervention optimization. Trial Registration OMON NL46439.068.13; https://onderzoekmetmensen.nl/en/trial/24803
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Contextual Psychiatry, Psychiatry Research Group, Department of Neurosciences, KU Leuven, Leuven, Belgium.
- Department of Psychology, Health & Technology, Faculty of Behavioural, Management and Social Sciences (BMS), University of Twente, Enschede, Netherlands.
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.
- Department of Lifespan Psychology, Faculty of Psychology, Open University, Heerlen, Netherlands.
- Center for Clinical Psychiatry, Psychiatry Research Group, Department of Neurosciences, KU Leuven, Leuven, Belgium.
- Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
ORCID-Profile: Evelyne van Aubel, Thomas Vaessen, Lotte Uyttebroek, Henrietta Steinhart, Annelie Beijer-Klippel, Tim Batink, Ruud van Winkel, Lieuwe de Haan, Mark van der Gaag, Thérèse van Amelsvoort, Machteld Marcelis, Frederike Schirmbeck, Ulrich Reininghaus, Inez Myin-Germeys
Förderung
- EPA
Zitieren
APA
van Aubel, E., Vaessen, T., Uyttebroek, L., Steinhart, H., Beijer-Klippel, A., Batink, T., van Winkel, R., de Haan, L., van der Gaag, M., van Amelsvoort, T., Marcelis, M., Schirmbeck, F., Reininghaus, U., & Myin-Germeys, I. (2024). Engagement and Acceptability of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Secondary Findings From a Multicenter Randomized Controlled Trial. JMIR Formative Research. https://doi.org/10.2196/57109
Vancouver
van Aubel E, Vaessen T, Uyttebroek L, Steinhart H, Beijer-Klippel A, Batink T, et al. Engagement and Acceptability of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Secondary Findings From a Multicenter Randomized Controlled Trial. JMIR Formative Research. 2024. doi:10.2196/57109
BibTeX
@article{vanAubel2024,
author = {van Aubel, Evelyne and Vaessen, Thomas and Uyttebroek, Lotte and Steinhart, Henrietta and Beijer-Klippel, Annelie and Batink, Tim and van Winkel, Ruud and de Haan, Lieuwe and van der Gaag, Mark and van Amelsvoort, Thérèse and Marcelis, Machteld and Schirmbeck, Frederike and Reininghaus, Ulrich and Myin-Germeys, Inez},
title = {Engagement and Acceptability of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Secondary Findings From a Multicenter Randomized Controlled Trial},
journal = {JMIR Formative Research},
year = {2024},
doi = {10.2196/57109}
}
EUVIMED